Table 1. Clinical characteristics of patients in LP and SP groups.
| Variables | SP | LP | P value |
|---|---|---|---|
| Patients, n | 34 | 31 | |
| Male sex, n (%) | 18 (52.9) | 14 (45.2) | 0.622 |
| Age, years | 69.5 (57–78) | 80 (63–85) | 0.025 * |
| Height, cm | 158.8 (151.7–166.4) | 157 (147–162) | 0.348 |
| Body weight, kg | 57.3 (48.4–65.6) | 60.7 (50.1–75.5) | 0.287 |
| BMI, kg/m2 | 22.4 (20.2–25.3) | 25.5 (22.2–29.5) | 0.019 * |
| Plasma albumin, g/dl | 4.0 (3.2–4.3) | 3.2 (2.7–3.6) | 0.002 * |
| ASA class (IQR) | 2 (2 ‒ 2) | 2 (2 ‒ 3) | 0.061 |
| Duration of surgery, min | 146 (93–204) | 118 (47–233) | 0.393 |
| Total duration of general anesthesia, min | 193 (135–256) | 169 (114–331) | 0.932 |
| Total dose of remimazolam administered, mg | 75.4 (47.8–110.0) | 67.1 (44.1–119.0) | 0.958 |
| Administration of flumazenil, n (%) | 0 | 16 (51.6) |
Data are median (IQR; 25% ‒ 75% interquartile range).
*significant difference.
SP, short period (time to extubation < 15 min); LP, long period (time to extubation ≥ 15 min); BMI, body mass index; ASA, American Society of Anesthesiologists.